Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed EBT Margin for 6 consecutive years, with 110.65% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 708.0% to 110.65% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 140.18% through Dec 2025, up 2690.0% year-over-year, with the annual reading at 140.18% for FY2025, 2690.0% up from the prior year.
  • EBT Margin hit 110.65% in Q4 2025 for Rapid Micro Biosystems, up from 146.68% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 110.65% in Q4 2025 to a low of 442.08% in Q1 2021.
  • Historically, EBT Margin has averaged 246.52% across 5 years, with a median of 227.57% in 2023.
  • Biggest five-year swings in EBT Margin: plummeted -77100bps in 2021 and later surged 19969bps in 2023.
  • Year by year, EBT Margin stood at 279.78% in 2021, then crashed by -34bps to 375.86% in 2022, then soared by 53bps to 176.17% in 2023, then skyrocketed by 33bps to 117.73% in 2024, then rose by 6bps to 110.65% in 2025.
  • Business Quant data shows EBT Margin for RPID at 110.65% in Q4 2025, 146.68% in Q3 2025, and 163.14% in Q2 2025.